These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 17311958)

  • 21. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers.
    Dusheiko GM; Hoofnagle JH; Cooksley WG; James SP; Jones EA
    J Clin Invest; 1983 May; 71(5):1104-13. PubMed ID: 6602149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). IV. Distinct H-2-linked Ir genes control antibody responses to different HBsAg determinants on the same molecule and map to the I-A and I-C subregions.
    Milich DR; Leroux-Roels GG; Louie RE; Chisari FV
    J Exp Med; 1984 Jan; 159(1):41-56. PubMed ID: 6198427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization.
    Qiu SJ; Lu L; Qiao C; Wang L; Wang Z; Xiao X; Qian S; Fung JJ; Ye SL; Bonham CA
    J Cancer Res Clin Oncol; 2005 Jul; 131(7):429-38. PubMed ID: 15818505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between in vivo humoral and in vitro cellular immune responses following immunization with hepatitis B surface antigen (HBsAg) vaccines.
    Leroux-Roels G; Van Hecke E; Michielsen W; Voet P; Hauser P; Pêtre J
    Vaccine; 1994 Jul; 12(9):812-8. PubMed ID: 7975860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose HBsAg CS-γ-PGA nanogels induce potent protective immune responses against HBV infection.
    Wang H; Han Q; Zhao H; Xu D; Zhang J
    Eur J Pharm Biopharm; 2018 Mar; 124():82-88. PubMed ID: 29247691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA.
    Shen E; Li L; Li L; Feng L; Lu L; Yao Z; Lin H; Wu C
    Cell Mol Immunol; 2007 Apr; 4(2):113-20. PubMed ID: 17484805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of anti-hepatitis B surface antigen (HBsAg) antibodies in HBsAg producing transgenic mice: a possible way of circumventing "nonresponse" to HBsAg.
    Mancini M; Hadchouel M; Tiollais P; Pourcel C; Michel ML
    J Med Virol; 1993 Jan; 39(1):67-74. PubMed ID: 7678639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine.
    Krawczyk A; Ludwig C; Jochum C; Fiedler M; Heinemann FM; Shouval D; Roggendorf M; Roggendorf H; Lindemann M
    Vaccine; 2014 Sep; 32(39):5077-82. PubMed ID: 24975813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
    Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
    Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of immunogenecity of liver dendritic cells from mouse with chronic hepatitis.
    Abe M; Kajino K; Akbar SM; Yamamura K; Onji M; Hino O
    Int J Mol Med; 2002 Jan; 9(1):71-6. PubMed ID: 11745000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of hepatitis B surface antigen-pulsed dendritic cells from immunosuppressed murine hepatitis B virus carrier: evaluation of immunogenicity of antigen-pulsed dendritic cells in vivo.
    Furukawa S; Akbar SM; Hasebe A; Horiike N; Onji M
    Immunobiology; 2004; 209(7):551-7. PubMed ID: 15568619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
    Zheng BJ; Zhou J; Qu D; Siu KL; Lam TW; Lo HY; Lee SS; Wen YM
    J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B lymphocytes regulate dendritic cell (DC) function in vivo: increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation.
    Moulin V; Andris F; Thielemans K; Maliszewski C; Urbain J; Moser M
    J Exp Med; 2000 Aug; 192(4):475-82. PubMed ID: 10952717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune tolerance against HBV can be overcome in HBV transgenic mice by immunization with dendritic cells pulsed by HBVsvp.
    Farag MM; Tedjokusumo R; Flechtenmacher C; Asen T; Stremmel W; Müller M; Protzer U; Weigand K
    Vaccine; 2012 Sep; 30(42):6034-9. PubMed ID: 22867720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Feasibility of using hepatitis B virus surface antigen as target antigen in immunogen therapy against cancer].
    Qiu S; Ye S; Tang Z; Qian S; Li L
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(4):253-6. PubMed ID: 11953174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAg.
    Huang Y; Chen Z; Jia H; Wu W; Zhong S; Zhou C
    Clin Immunol; 2006 Jun; 119(3):280-90. PubMed ID: 16531121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.